Indication
Valvular Heart Disease
8 clinical trials
9 products
1 drug
Clinical trial
Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular Outcomes (mTECH-Rehab): A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.Status: Completed, Estimated PCD: 2024-04-30
Product
ProtaminClinical trial
Prothrombin Complex Concentrate and Fresh Frozen Plasma in Viscoelastic Test-based Goal-directed Bleeding Management in Cardiac SurgeryStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Product
Fresh Frozen PlasmaClinical trial
Sugammadex Titration for Reversal of Rocuronium or Vecuronium in Cardiac Surgery PatientsStatus: Completed, Estimated PCD: 2022-11-10
Product
SugammadexClinical trial
Effect of Milrinone on the Right Ventricular Strain in Cardiac SurgeryStatus: Recruiting, Estimated PCD: 2024-12-01
Product
MilrinoneClinical trial
Canadian EdoxAban (Lixiana®) Registry in Patients With ATrial Fibrillation and/or ATrial Flutter With Confirmed ValvUlar HeaRt DiseasE (CAPTURE)Status: Active (not recruiting), Estimated PCD: 2025-01-31
Product
EdoxabanClinical trial
Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta SurgeryStatus: Recruiting, Estimated PCD: 2024-11-01
Product
Ampicillin-sulbactamClinical trial
Topical Application Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac SurgeryStatus: Completed, Estimated PCD: 2022-12-31
Product
Tranexamic AcidDrug
Varlilumab